Colgate-Palmolive Company $CL Shares Acquired by RWA Wealth Partners LLC

Key Points

• RWA Wealth Partners LLC has increased its stake in Colgate-Palmolive by 33.9%, owning 246,846 shares worth approximately $23.1 million after acquiring an additional 62,523 shares.
• The company reported earnings per share of $0.92 for the last quarter, exceeding analysts' expectations of $0.89, with a quarterly revenue of $5.11 billion.
• Colgate-Palmolive's recent quarterly dividend was $0.52, offering an annualized yield of 2.4% with a payout ratio of 58.43%.

RWA Wealth Partners LLC increased its stake in Colgate-Palmolive Company (NYSE:CL - Free Report) by 33.9% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 246,846 shares of the company's stock after purchasing an additional 62,523 shares during the period. RWA Wealth Partners LLC's holdings in Colgate-Palmolive were worth $23,129,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in CL. Nuveen LLC bought a new stake in shares of Colgate-Palmolive in the 1st quarter worth approximately $217,593,000. Goldman Sachs Group Inc. lifted its holdings in shares of Colgate-Palmolive by 34.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 7,980,387 shares of the company's stock worth $747,762,000 after purchasing an additional 2,045,191 shares during the last quarter. Deutsche Bank AG lifted its holdings in shares of Colgate-Palmolive by 35.6% in the 4th quarter. Deutsche Bank AG now owns 6,922,994 shares of the company's stock worth $629,369,000 after purchasing an additional 1,816,865 shares during the last quarter. Diamond Hill Capital Management Inc. raised its stake in Colgate-Palmolive by 45.0% during the 1st quarter. Diamond Hill Capital Management Inc. now owns 5,562,968 shares of the company's stock valued at $521,250,000 after acquiring an additional 1,727,105 shares in the last quarter. Finally, Castlekeep Investment Advisors LLC bought a new stake in Colgate-Palmolive during the 4th quarter valued at $111,738,000. Institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Price Performance

Shares of CL traded down $0.5010 during midday trading on Friday, reaching $85.7790. The stock had a trading volume of 4,087,413 shares, compared to its average volume of 5,056,872. Colgate-Palmolive Company has a 52 week low of $82.40 and a 52 week high of $109.30. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57. The firm's 50 day moving average price is $87.60 and its 200-day moving average price is $89.91. The company has a market capitalization of $69.33 billion, a P/E ratio of 24.10, a P/E/G ratio of 4.49 and a beta of 0.35.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its quarterly earnings data on Friday, August 1st. The company reported $0.92 EPS for the quarter, topping analysts' consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The company had revenue of $5.11 billion for the quarter, compared to the consensus estimate of $5.03 billion. During the same quarter in the previous year, the business earned $0.91 EPS. The company's quarterly revenue was up 1.0% compared to the same quarter last year. On average, analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 18th were paid a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date of this dividend was Friday, July 18th. Colgate-Palmolive's payout ratio is currently 58.43%.

Analyst Ratings Changes

Several analysts have weighed in on the company. UBS Group cut their target price on Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating on the stock in a research note on Thursday, July 17th. Barclays lifted their target price on Colgate-Palmolive from $86.00 to $87.00 and gave the company an "equal weight" rating in a research note on Tuesday, July 15th. Wells Fargo & Company cut their target price on Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating on the stock in a research note on Monday, August 4th. Wall Street Zen downgraded Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Wednesday, May 7th. Finally, Morgan Stanley cut their target price on Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating on the stock in a research note on Monday, August 4th. Seven equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $98.92.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.